Search results
Biotech CEL-SCI gets FDA go-ahead to conduct investigational cancer immunotherapy study - Maryland...
The Daily Record· 3 days agoThe FDA agreed to a 212-person confirmatory Registration Study based on the strength of the safety and survival benefit data in the selected target population from the prior ...
Middle East Marine Put on Blast for 'Worst Case of Serial Seafarer Abandonment Ever Seen'
MarineLink· 5 days ago...International Transport Workers’ Federation (ITF) is calling out Dubai-based ship management ...
Graduation season survival guide
Minneapolis-St. Paul Star Tribune· 5 days agoGraduation season is a time of celebrating accomplishments and extending best wishes for life's next chapter, but it can also be a time of stress when...
Discover wellbeing and how to live a healthy life with FitnessGenes
Daily Express· 3 days agoThrough the test FitnessGenes pinpoints fundamental factors such as food choices, activity, hormone...
Malaysia's 'orangutan diplomacy' pitches apes for palm oil, their greatest threat
Semafor via Yahoo News· 2 days agoThe Malaysian government announced it would give countries that import palm oil orangutans as a way...
Revolutionary mRNA Cancer Vaccine Shows Immense Promise in First-Ever Human Clinical Trial
SciTechDaily· 21 hours agoIn a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine created at the...
Kite and Arcellx to start Phase 3 trial for myeloma therapy By Investing.com
Investing.com· 2 days agoREDWOOD CITY, Calif. & SANTA MONICA, Calif. - Kite, a GileadCompany (NASDAQ: GILD), and Arcellx,...
A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
Digital Journal· 3 days agoSHELTON, CT / ACCESSWIRE / May 8, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that the ...
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
Boston Herald· 18 hours agoWhen doctors began using the drug sotorasib in 2021 with high expectations for its innovative...
NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York...
Morningstar· 1 day agoSHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, today announces ...